QED Connect Inc (QEDN)

[Indica]

QED Connect, Inc. (OTCBB: QEDN) FULL REPORT
QED Connect, Inc. has acquired Emerald Med Farms, LLC, a California based medical marijuana company. The company will be a wholly owned subsidiary of QED Connect, Inc.

Emerald Med Farms is a newly launched enterprise that cultivates, harvests cannabis for the medical marijuana industry with a business philosophy to be the “Cannabis Purveyors of the Highest Quality”. They have developed an exceptional methodology of employing a continuous sterile environment during all stages of operations to ensure that the product maintains the upmost quality and purity. Their facilities will be state-of-the-art utilizing multi-state proven methods to produce the highest of quality medical cannabis. Emerald Med Farms management and key personnel have a successful track record including a Master Grower with over 27 years of experience in California with both inside and outside growing for all styles of plant and vegetation. The company has also built a strong network of industry professionals ranging from research facilities to individual scientist from around the globe to support their endeavors. The Company operations are in full compliance to the medical marijuana California Co-Operative. The Co-Op maintains a roster of registered patients under “right to grow” which defines the number of plants per patient per script.

Emerald Med Farms has a marijuana crop in the process of maturing that is expected to be ready within the next 30 to 45 days for harvesting. The current crop is estimated to yield between 3 and 4 pounds per plant and, upon the successful harvesting of these strains of marijuana, the product will be distributed through a Cooperative of California medical dispensaries.

The marijuana plants are from two strains: 1) The OG Kush Strain which was originally from Northern California and has quickly become known around the world for its distinct aroma and strong effects. The OG Kush strain is one of the most popular medical marijuana strains grown and sold by dispensaries today. 2) Sour Diesel Strain which is named after its pungent, diesel-like aroma. This fast-acting strain delivers energizing, dreamy cerebral effects that provides stress, pain, and depression relief and provides long-lasting relief making it a top choice among medical patients.

The company has approved a 40% reduction in its authorized shares. The Company will reduce the number of authorized common shares from 1,000,000,000 to 600,000,000. Additionally, the Series A preferred shares shall no longer have conversion rights to common shares. QED is working with its registered agent, Corporate Creations, to file an amendment to the Articles of Incorporation with the Secretary of the State of New York and will be reflected in subsequent filings.

QEDN has completed its filings for year end 2013 and the first quarter 2014 to be in full compliance with its disclosures and financials as required by the OTC Markets guidelines. QED’s status on OTC Markets is now listed as OTC Pink Current Information.